Expand MLYS Menu
MLYS MENU

MLYS Latest Press Releases

-- November 11, 2024 --

Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- November 5, 2024 --

Mineralys Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- November 4, 2024 --

Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024 Globe Newswire 4:05 PM

-- October 30, 2024 --

Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension Globe Newswire 8:00 AM

-- October 22, 2024 --

Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024 Globe Newswire 8:00 AM

-- September 25, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc. - MLYS PRNewswire 3:26 PM
Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension Globe Newswire 8:00 AM

-- September 22, 2024 --

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! Globe Newswire 4:00 PM

-- September 20, 2024 --

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! Business Wire 4:00 PM

-- September 19, 2024 --

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! PRNewswire 4:00 PM

-- September 17, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc. - MLYS PRNewswire 6:35 PM

-- September 16, 2024 --

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! Globe Newswire 4:00 PM

-- September 12, 2024 --

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! Business Wire 4:00 PM

-- September 11, 2024 --

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! PRNewswire 4:00 PM

-- September 10, 2024 --

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! Globe Newswire 4:00 PM

-- September 9, 2024 --

MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Globe Newswire 5:30 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc. - MLYS PRNewswire 5:15 PM

-- September 3, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc. - MLYS PRNewswire 5:44 PM

-- August 28, 2024 --

Mineralys Therapeutics to Participate in the Wells Fargo Healthcare Conference Globe Newswire 8:00 AM

-- August 26, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc. - MLYS PRNewswire 6:47 PM

-- August 13, 2024 --

Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- August 5, 2024 --

Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024 Globe Newswire 4:05 PM